Skip to content
Breaking News

Breaking News

  • Home
  • World
  • Business
  • Health
  • Entertainment
  • Life Style
  • Sports
  • Toggle search form

Anne Wojcicki to buy back 23andMe and its data for $305 million

Posted on June 13, 2025 By Admin No Comments on Anne Wojcicki to buy back 23andMe and its data for $305 million


23andMe founder Anne Wojcicki speaks during a House Committee on Oversight and Government Reform hearing in Washington, D.C., on June 10, 2025.

Andrew Harnik | Getty Images

Anne Wojcicki, the co-founder and former CEO of 23andMe, has regained control over the embattled genetic testing company after her new nonprofit, TTAM Research Institute, outbid Regeneron Pharmaceuticals, the company announced Friday. 

TTAM will acquire substantially all of 23andMe’s assets for $305 million, including its Personal Genome Service and Research Services business lines as well as telehealth subsidiary Lemonaid Health. It’s a big win for Wojcicki, who stepped down from her role as CEO when 23andMe filed for Chapter 11 bankruptcy protection in March.

Last month, Regeneron announced it would purchase most of 23andMe’s assets for $256 million after it came out on top during a bankruptcy auction. But Wojcicki submitted a separate $305 million bid through TTAM and pushed to reopen the auction. TTAM is an acronym for the first letters of 23andMe, according to The Wall Street Journal.

“I am thrilled that TTAM Research Institute will be able to continue the mission of 23andMe to help people access, understand and benefit from the human genome,” Wojcicki said in a statement.

23andMe gained popularity because of its at-home DNA testing kits that gave customers insight into their family histories and genetic profiles. The five-time CNBC Disruptor 50 company went public in 2021 via a merger with a special purpose acquisition company. At its peak, 23andMe was valued at around $6 billion.

The company struggled to generate recurring revenue and stand up viable research and therapeutics businesses after going public, and it has been plagued by privacy concerns since hackers accessed the information of nearly seven million customers in 2023.

TTAM’s acquisition is still subject to approval by the U.S. Bankruptcy Court for the Eastern District of Missouri.

Don’t miss these insights from CNBC PRO



Source link

Health Tags:Breaking News: Business, Breaking News: Technology, business news, Enterprise, Health care industry, Media, Regeneron Pharmaceuticals Inc, technology

Post navigation

Previous Post: CDC reports high levels of flu activity in 25 states
Next Post: Novak Djokovic makes political statement about Kosovo after first-round French Open win | CNN

More Related Articles

Do you know the signs of skin cancer? – SUCH TV Health
How to prevent a heart attack? Health
FDA approves two new Abbott over-the-counter continuous glucose monitors Health
Study warns declining child vaccine coverage puts millions at risk – SUCH TV Health
Weight Loss Journey: Supercharge Your Diet With These 5 Nutrient-Packed Super Seeds Health
Coffee boosts healthy aging odds for women: 30-year study | The Express Tribune Health

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recent Posts

  • Spurs target Gibbs-White signs new Forest deal
  • Toxic air exposure significantly raises dementia risk, finds study
  • This Gorgeous European Country Allows Tourists Without A Schengen Visa
  • Pakistan joins global AI community | The Express Tribune
  • Thailand and Cambodia Trade Heavy Fire in Escalating Conflict – SUCH TV

Categories

  • Business
  • Entertainment
  • Health
  • Life Style
  • Sports
  • World

Copyright © 2025 Breaking News.

Powered by PressBook Blog WordPress theme